Veterans

Phase 2 Multicenter Randomized Placebo-controlled, Double-blind Study to Assess Safety/Efficacy of Inhaled Cannabis in Veterans for PTSD

Study aims to re-examine inhaled cannabis for treating PTSD, with Phase 2 study assessing high THC cannabis versus placebo for managing symptoms and pain in 360 veterans across U.S.

Sue Sisley, Shane Pennington

PS2023 Depression Health Equity Policy and Advocacy Psychedelic Assisted Therapy PTSD Veterans

Healing Our Heroes: A Dinner Honoring Veterans and First Responders

Veterans, First Responders, and families supporting psychedelic medicine will be honored at the conference for their mental health challenges and the urgent need for better care and resources.

Itzel Barakat, Justin LaPree

PS2023 Ancestral Knowledge Healing for All Plant Medicine Psychedelic Science Research Veterans

Veterans and the Journey of Plant Medicine

Veterans find healing through traditional psychedelics, beyond clinical research. Explore how veteran communities use psychedelics in ceremonial settings for therapeutic benefits.

Jesse Gould, Grace Blest-Hopley, Zachary Skiles

PS2023 Healing for All Indigenous People Policy and Advocacy Psychedelic Science Research Veterans

New Federal Support for Research

Veterans find healing through traditional psychedelics. Learn how veteran communities incorporate psychedelics in ceremonial settings for therapeutic benefits.

Juliana Mercer, SGT(R) Jonathan Lubecky

PS2023 Anxiety Depression Ibogaine PTSD Research Veterans

Ibogaine-Magnesium: the Stanford Traumatic Injury to the CNS (MISTIC) Protocol – A Pilot Study in Special Operations Veterans with Traumatic Brain Injuries

Stanford conducted the first trial of Magnesium-Ibogaine on Special Operations Forces Veterans with traumatic brain injury, showing significant functional improvements and high remission rates for comorbid psychiatric disorders. Further controlled

Nolan Williams

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic-AT Research Veterans

The Potential of Psychedelic Therapies for Veterans and their Families

Session features the unlikely journey of psychedelic therapy into the VA and updates on current psychedelic research programs.

Marcus Capone, Amber Capone

PS2023 Psychedelic Assisted Therapy PTSD Veterans

PTSD. The Other War Most Combat Veterans Fight. Psychedelics and Finally Coming Home.

Bob Parsons, a Vietnam War veteran and entrepreneur, advocates for psychedelic therapies to address PTSD. He shares how psychedelics helped him heal and is now helping other veterans.

Bob Parsons

PS2023 Depression Health Conditions PTSD Substance Use Disorder Veterans

Trauma Support for the Families of Veterans

Families of veterans are affected by trauma, depression, and addiction. Session explores healing for families impacted by veterans' struggles.

Anne Wagner, Lauren Myers, Andrea Lucie

PS2023 Social Justice Veterans

Supporting Veterans from Marginalized Communities

Dr. Smith and Dr. Jones explore advancements in artificial intelligence and its impact on society, highlighting key ethical considerations in the field.

Kim Jurovieky, Craig Cunningham, Heather R King, Steven Huang

PS2023 Cannabis Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Substance Use Disorder Veterans

Psychedelics, Exceptionalism, and Other Drugs

Psychedelics show promise in treating pain and addiction. Psychedelic policy reform can inspire bipartisan coalitions and benefit drug policy reform overall.

Ethan Nadelmann